Home
>
National Drug Code (NDC)
>
XIFAXAN
XIFAXAN - 65649-303-02 - (RIFAXIMIN)
Drug Information of XIFAXAN
| Product NDC: | 65649-303 |
| Proprietary Name: | XIFAXAN |
| Non Proprietary Name: | RIFAXIMIN |
| Active Ingredient(s): | 550 mg/1 & nbsp; RIFAXIMIN |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of XIFAXAN
| Product NDC: | 65649-303 |
| Labeler Name: | Salix Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021361 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20100501 |
Package Information of XIFAXAN
| Package NDC: | 65649-303-02 |
| Package Description: | 60 TABLET in 1 BOTTLE (65649-303-02) |
NDC Information of XIFAXAN
| NDC Code | 65649-303-02 |
| Proprietary Name | XIFAXAN |
| Package Description | 60 TABLET in 1 BOTTLE (65649-303-02) |
| Product NDC | 65649-303 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | RIFAXIMIN |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20100501 |
| Marketing Category Name | NDA |
| Labeler Name | Salix Pharmaceuticals, Inc. |
| Substance Name | RIFAXIMIN |
| Strength Number | 550 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Rifamycin Antibacterial [EPC],Rifamycins [Chemical/Ingredient] |
